Cell kinetic parameters were determined in 32 patients with breast cancer following intravenous [3H]thymidine injection. The mean labelling index (LI) was 8.6, range 1.2 to 24.1. The LI increased significantly with increased stage of disease. The highest values were noted in patients with chest wall
Compartmental modelling of the uptake kinetics of the anti-cancer agent topotecan in human breast cancer cells
β Scribed by Neil D. Evans; Rachel J. Errington; Michael J. Chapman; Paul J. Smith; Michael J. Chappell; Keith R. Godfrey
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 755 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0890-6327
- DOI
- 10.1002/acs.856
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The activity of the __de novo__ pyrimidine biosynthetic pathway in the MCF7 breast cancer cells was 4.4βfold higher than that in normal MCF10A breast cells. Moreover, while pyrimidine biosynthesis in MCF10A was tightly regulated, increasing as the culture matured and subsequently downβr
## Abstract Suramin, a nonβspecific growth factor antagonist, is currently under investigation for treatment of cancer patients. We studied its action on 6 different human breastβcancer cell lines in vitro. In complete growth medium, pleiotropic effects were observed with respect to cell proliferat
## Abstract Metastasis (the spread of cancer from a primary tumor to secondary organs) is responsible for most cancer deaths. The ability to follow the fate of a population of tumor cells over time in an experimental animal would provide a powerful new way to monitor the metastatic process. Here we